Neutral
Immunome, Inc. $IMNM Shares Sold by EcoR1 Capital LLC
EcoR1 Capital LLC reduced its holdings in Immunome, Inc. (NASDAQ:IMNM – Free Report) by 30.0% in the fourth quarter, HoldingsChannel reports. The firm...
Neutral
EcoR1 Capital LLC reduced its holdings in Immunome, Inc. (NASDAQ:IMNM – Free Report) by 30.0% in the fourth quarter, HoldingsChannel reports. The firm...
Immunome, Inc. (IMNM) is nearing the launch of Varegacestat, a drug showing strong Phase III data for desmoid tumors, including rapid pain reduction a...